
Per agreement, facility will be producing over 100 million doses annually for use in African Union
Per agreement, facility will be producing over 100 million doses annually for use in African Union
Robotic filling and capping equipment to be installed in NIBRT’s global bioprocessing training and research center
Plans a multi-phase, $100 million expansion, adding biologics drug substance manufacturing capabilities
Deal allows CDMO to quickly expand its drug delivery technologies in the US
Will produce plasmid DNA-based therapies, mRNA vaccine materials
CDMO looks to strengthen its presence in Belgium, Sweden and the Netherlands
Biopharma company plans for facility to also serve as its new HQ
As customer base grows, packaging company decides to wrap global divisions under one name
Latest deal expands CDMO’s biologics expertise
New large-scale plant in Barcelona part of company's capacity-expansion pursuits to capitalize on biopharma's increased demand for lyophilization equipment
Outlining the business-vital areas pharma organizations should consider today in energy risk management, including the value of resiliency
Mission is to expand its collection of mRNA vaccines beyond the Covid-19 pandemic
Mourenx location will install new equipment, add hires in project as part of the France Relance recovery plan
Facility will focus on rAAV clinical, commercial gene therapy products
Join forces on tamper-evident security for luer-lock syringes
Acquisition to expand presence in genomic medicine
Aims to enhance company's mRNA and viral vector capabilities
Horizon Therapeutics to purchase production facility from Irish specialty care company
A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories
Newly licensed US facility to increase availability of company's influenza vaccine
Health insurer Anthem joins BCBS organizations to form CivicaScript
Commercial-stage company will work with cell therapy partners to advance late-stage clinical programs
Will help UK consortium advance oral solid dosage medicines production
Site expected to begin operations by January 2022
Company's PA campus will be growing to 300,000 square feet